MCRB compared with GENB: revenue, margins and what each company keeps, and the suppliers and customers both name

MCRBSeres Therapeutics, Inc.

Mkt capRevenueRevenue

GENBGenerate Biomedicines, Inc.

Mkt capRevenueRevenue

Compare

MCRBSeres Therapeutics, Inc.

GENBGenerate Biomedicines, Inc.

Price

Mkt cap

Revenue

Earnings history

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

last 4 reports each · paired by recencyMethod ›

MCRB1 of 4 reports

0 of 1at or beyond implied

Reportimpliedrealized× implied

Q2 FY26±41.0%▼−4.67%×0.11

GENB1 of 4 reports

Reportimpliedrealized× implied

Q2 FY26—▼−4.14%—

= impliedMCRB realized, solidGENB realized, hatchedOne scale, both sides: full bar = 42%× = |realized| ÷ impliedSource: market data

MCRBSeres Therapeutics, Inc.

1.76▼−9.72%· post 1.76

Mkt cap$17.6MRevenue$736,000Q2 FY26

GENBGenerate Biomedicines, Inc.

14.49▼−8.10%· post 14.49

ClosedOct 30 '26

Mkt cap$1.9BRevenue$6MQ2 FY26

Compare

ClosedOct 30 '26

MCRBSeres Therapeutics, Inc.

GENBGenerate Biomedicines, Inc.

1.76▼−9.72%post 1.76

Price

14.49▼−8.10%post 14.49

$17.6M

Mkt cap

$1.9B

Q2 FY26$736,000

Revenue

$6MQ2 FY26

MCRB1.76▼−9.72%vsGENB14.49▼−8.10%ClosedOct 30 '26